ISSN:

Journal Home

Journal Guideline

Synergy Q3 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Synergy is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 15. It has a price of 1620 €. It has an SJR impact factor of 0,354 and it has a best quartile of Q3. It has an SJR impact factor of 0,354.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q3) Pharmacology (medical) (Q3) Cell Biology (Q4) Molecular Biology (Q4)

Price

1620 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,354

SJR Impact factor

15

H Index

0

Total Docs (Last Year)

9

Total Docs (3 years)

0

Total Refs

24

Total Cites (3 years)

9

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Adhesion and Migration Q3
BMC Molecular and Cell Biology Q3
International Journal of Stem Cells Q3
Current Stem Cell Reports Q3
Journal of Bioenergetics and Biomembranes Q3

Compare this journals

Synergy Q3 Unclaimed

1620 €

NPD

0 €

Metrics

0,354

15

0

9

0

24

9

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of Synergy?